![Christian C. Fritz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dr. Christian C.
Fritz is Vice President-Biology at Syros Pharmaceuticals, Inc.
Dr. Fritz was previously employed as a Principal by Max-Planck Institute of Psychiatry, Senior Director-Cancer Cell Biology by Infinity Pharmaceuticals, Inc., and Senior Scientist by Millennium Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Hannover and a doctorate degree from Universität zu Köln.
Anciens postes connus de Christian C. Fritz
| Sociétés | Poste | Fin |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2017 |
Max-Planck Institute of Psychiatry
 Max-Planck Institute of Psychiatry The Max Planck Institute of Psychiatry is an interdisciplinary research and clinical center focused on understanding the causes of psychiatric disorders, particularly stress-related conditions such as depression, anxiety, and psychosis. The company is based in Munich, Germany. The institute integrates basic science, clinical research, and patient care to develop improved, personalized diagnostic methods, therapies, and preventive strategies. It operates a research hospital offering outpatient, day, and inpatient services, where scientific findings are translated into clinical practice. Research areas include genetics, neurobiology, emotion research, psychophysiology, and precision psychiatry, with studies on immune system dysregulation, circadian rhythms, and AI models predicting treatment-related risks. The institute fosters collaboration among clinicians and scientists and provides career and training opportunities, including international PhD programs, integrated doctoral and residency programs, and participation in graduate schools. Educational outreach includes seminars, public lectures, and practical training for medical students. The institute also engages in historical reflection regarding its past involvement in unethical practices and undertakes projects to honor victims and promote remembrance. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Christian C. Fritz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hannover
 University of Hannover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max-Planck Institute of Psychiatry
Max-Planck Institute of Psychiatry The Max Planck Institute of Psychiatry is an interdisciplinary research and clinical center focused on understanding the causes of psychiatric disorders, particularly stress-related conditions such as depression, anxiety, and psychosis. The company is based in Munich, Germany. The institute integrates basic science, clinical research, and patient care to develop improved, personalized diagnostic methods, therapies, and preventive strategies. It operates a research hospital offering outpatient, day, and inpatient services, where scientific findings are translated into clinical practice. Research areas include genetics, neurobiology, emotion research, psychophysiology, and precision psychiatry, with studies on immune system dysregulation, circadian rhythms, and AI models predicting treatment-related risks. The institute fosters collaboration among clinicians and scientists and provides career and training opportunities, including international PhD programs, integrated doctoral and residency programs, and participation in graduate schools. Educational outreach includes seminars, public lectures, and practical training for medical students. The institute also engages in historical reflection regarding its past involvement in unethical practices and undertakes projects to honor victims and promote remembrance. | |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
